NanoString Technologies Inc (NSTG)

18.02
NASDAQ : Health Care
Prev Close 18.02
Day Low/High 0.00 / 0.00
52 Wk Low/High 11.30 / 23.45
Avg Volume 181.80K
Exchange NASDAQ
Shares Outstanding 21.00M
Market Cap 397.82M
EPS -2.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Commit To Purchase NanoString Technologies At $20, Earn 20.9% Annualized Using Options

Commit To Purchase NanoString Technologies At $20, Earn 20.9% Annualized Using Options

Investors eyeing a purchase of NanoString Technologies Inc shares, but cautious about paying the going market price of $22.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April put at the $20 strike, which has a bid at the time of this writing of $1.20.

The Scientist Magazine Names NanoString Technologies NCounter Vantage 3D Panels A Top 10 Innovation Of 2016

The Scientist Magazine Names NanoString Technologies NCounter Vantage 3D Panels A Top 10 Innovation Of 2016

Assay portfolio enables simultaneous analysis of DNA, RNA, and protein for cancer research

NanoString Technologies Highlights Advances In Precision Oncology At The 58th Annual Meeting Of The American Society Of Hematology

NanoString Technologies Highlights Advances In Precision Oncology At The 58th Annual Meeting Of The American Society Of Hematology

Abstracts Demonstrate the Value of the nCounter Platform for Disease Characterization, Translational Research and Diagnostic Applications in Hematology

NanoString Launches Technology Access Program (TAP) For Transformative Platform For High-Plex Digital Spatial Profiling

NanoString Launches Technology Access Program (TAP) For Transformative Platform For High-Plex Digital Spatial Profiling

nCounter-based system enables multiplex analysis of proteins and RNA in spatial context from Formalin-Fixed, Paraffin-Embedded (FFPE) samples

NanoString Technologies Releases Operating Results For Third Quarter Of 2016

NanoString Technologies Releases Operating Results For Third Quarter Of 2016

Revenue Growth of 53% Year-Over-Year Driven by Increased nCounter SPRINT Demand and Strong Commercial Execution

NanoString Technologies Presents Update On Hyb & Seq™ Next-Generation Sequencing Chemistry At ASHG Annual Meeting

NanoString Technologies Presents Update On Hyb & Seq™ Next-Generation Sequencing Chemistry At ASHG Annual Meeting

Library-Free Work Flow Goes From FFPE Tissue Sample to Sequencing in Less Than 60 Minutes

NanoString Enhances Solid Tumor Profiling With 3D Biology Capabilities For Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples

NanoString Enhances Solid Tumor Profiling With 3D Biology Capabilities For Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples

nCounter® Vantage 3D™ Solid Tumor Panels Enable Simultaneous Analysis of Single Nucleotide Variations (SNVs), mRNA, Fusion Genes, and Proteins on a Single Platform

NSTG Crosses Above Average Analyst Target

NSTG Crosses Above Average Analyst Target

In recent trading, shares of NanoString Technologies Inc have crossed above the average analyst 12-month target price of $20.60, changing hands for $20.75/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Commit To Purchase NanoString Technologies At $15, Earn 16.5% Annualized Using Options

Commit To Purchase NanoString Technologies At $15, Earn 16.5% Annualized Using Options

Investors eyeing a purchase of NanoString Technologies Inc stock, but cautious about paying the going market price of $16.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $15 strike, which has a bid at the time of this writing of $1.05.

NanoString Technologies Highlights Advances In Precision Oncology And Immunotherapy At The 52nd Annual Meeting Of The American Society Of Clinical Oncology (ASCO)

NanoString Technologies Highlights Advances In Precision Oncology And Immunotherapy At The 52nd Annual Meeting Of The American Society Of Clinical Oncology (ASCO)

More than 30 Abstracts Demonstrate the Value of the nCounter Platform for Disease Characterization, Translational Research and Diagnostic Applications in Cancer Research and Immuno-Oncology

Oversold Conditions For NanoString Technologies (NSTG)

Oversold Conditions For NanoString Technologies (NSTG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NanoString Technologies Releases Operating Results For First Quarter Of 2016

NanoString Technologies Releases Operating Results For First Quarter Of 2016

Revenue Growth Driven by Strong Consumable Pull-Through and Diagnostic Collaborations